Caxton Associates (New York)’s Frontline FRO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-33,077
Closed -$362K 507
2022
Q3
$362K Buy
+33,077
New +$362K 0.05% 295
2020
Q1
Sell
-42,490
Closed -$546K 465
2019
Q4
$546K Buy
42,490
+2,106
+5% +$22.9K 0.07% 160
2019
Q3
$367K Buy
+40,384
New +$326K 0.07% 205

Other funds holding FRO

Caxton Associates (New York)'s FRO Position: Q4 2022 in Review

Caxton Associates (New York) sold out of Frontline (FRO) in Q4 2022, closing a stake of 33,077 shares — an estimated $362K sold.

Caxton Associates (New York) first reported a position in FRO in Q3 2019 and held it in 3 quarters. The position peaked at $546K in Q4 2019. 155 funds tracked by Wall St. Rank hold FRO as of Q4 2022.

  • Caxton Associates (New York) reported no remaining Frontline position as of Q4 2022 after selling out during the quarter.
  • Caxton Associates (New York) sold 33,077 Frontline shares in Q4 2022, an estimated $362K.
  • Caxton Associates (New York) first reported a position in Frontline in Q3 2019 and held it in 3 quarters.
  • Caxton Associates (New York)'s Frontline position peaked at $546K in Q4 2019.
  • 155 funds tracked by Wall St. Rank held Frontline as of Q4 2022.

Based on Caxton Associates (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.